Evidence-based epileptology, randomized controlled trials, and SANAD: A critical clinical view

Epilepsia

Volumn 48, Issue 7, 2007, Pages 1268-1274

  Panayiotopoulos, Chrysostomos P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; TIAGABINE; VALPROIC ACID; VIGABATRIN;

CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG ERUPTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPSY; EVIDENCE BASED MEDICINE; FOCAL EPILEPSY; HIPPOCAMPAL SCLEROSIS; HUMAN; MONOTHERAPY; MYOCLONUS SEIZURE; NEUROIMAGING; NEUROSURGERY; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE EPILEPSY; VISUAL FIELD DEFECT;

ANTICONVULSANTS; EPILEPSY; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34447337303     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01172.x     Document Type: Note

References (44)

1. Barden J, Derry S, McQuay HJ, Moore RA 2006) Bias from industry trial funding? A framework, a suggested approach, and a negative result. Pain 121 : 207 218.
2. Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ 2004) Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 170 : 477 480.
3. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ 2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68 : 402 408.
4. Caplan LR 2001) Evidence based medicine: concerns of a clinical neurologist. J Neurol Neurosurg Psychiatry 71 : 569 574.
5. Chadwick D 1990) Diagnosis of epilepsy. Lancet 336 : 291 295.
6. Chadwick D 1994) Valproate in the treatment of partial epilepsies. Epilepsia 35 (suppl 5 S96 S98.
7. Chadwick D 1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 354 : 13 19.
8. Chan AW, Altman DG 2005a) Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365 : 1159 1162.
9. Chan AW, Altman DG 2005b) Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. Br Med J 330 : 753.
10. Chapell R, Reston J, Snyder D, Treadwell J, Treager S, Turkelson C 2003) Management of treatment-resistant epilepsy. Evid Rep Technol Assess (Summ.) 1 8.
11. Chaudhuri A 2006) Lessons for clinical trials from natalizumab in multiple sclerosis. Br Med J 332 : 416 419.
12. Crespel A, Genton P, Berramdane M, Coubes P, Monicard C, Baldy-Moulinier M, Gelisse P 2005) Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology 65 : 762 764.
13. Dickersin K, Straus SE, Bero LA 2007) Evidence based medicine: increasing, not dictating, choice. Br Med J 334 (suppl 1 s10 (http:/www.bmj.com/cgi/content/full/334/suppl_1/s10).
14. Eke T, Talbot JF, Lawden MC 1997) Severe persistent visual field constriction associated with vigabatrin. Br Med J 314 : 180 181.
15. Engel J Jr. 2006) Report of the ILAE classification core group. Epilepsia 47 : 1558 1568.
16. Ferrie CD, Livingston JH 2005) Epilepsy and evidence-based medicine: a vote of confidence in expert opinion from the National Institute for Clinical Excellence? Dev Med Child Neurol 47 : 204 206.
17. Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, Engel J Jr. 2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 : 470 472.
18. French JA 2004) Response: efficacy and tolerability of the new antiepileptic drugs. Epilepsia 45 : 1649 1651.
19. French JA 2006) How trial designs impact on guidelines. Epilepsy Res. 68 : 56 60.
20. French JA 2007) First-choice drug for newly diagnosed epilepsy. Lancet 369 : 970 971.
21. French JA, Kryscio RJ 2006) Active control trials for epilepsy: avoiding bias in head-to-head trials. Neurology 66 : 1294 1295.
22. Gamble C, Williamson PR, Chadwick DW, Marson AG 2006) A meta-analysis of individual patient responses to lamotrigine or carbama zepine monotherapy. Neurology 66 : 1310 1317.
23. Genton P, Gelisse P, Thomas P, Dravet C 2000) Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 55 : 1106 1109.
24. Gilliam F, Vazquez B, Sackellares JC, Chang GY, Messenheimer J, Nyberg J, Risner ME, Rudd GD 1998) An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 51 : 1018 1025.
25. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T 2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47 : 1094 1120.
26. Gotzsche PC, Hrobjartsson A, Johansen HK, Haahr MT, Altman DG, Chan AW 2007) Ghost authorship in industry-initiated randomised trials. PLoS Med 4 : e19.
27. King MA, Newton MR, Jackson GD, Berkovic SF 1998) Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic imaging study of 300 consecutive patients. Lancet 352 : 1007 1011.
28. Lindberger M, Alenius M, Frisen L, Johannessen SI, Larsson S, Malmgren K, Tomson T 2000) Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in refractory epilepsy add-on treatment. Epilepsia 41 : 1289 1295.
29. ls-Nielsen B, Chen W, Gluud C, Kjaergard LL 2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? J Am Med Assoc 290 : 921 928.
30. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, on behalf of the SANAD Study group 2007a) The SANAD study of eff ectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 : 1000 1015.
31. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, on behalf of the SANAD Study group 2007b) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369 : 1016 1026.
32. Panayiotopoulos CP 2000) An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 54 : 777.
33. Panayiotopoulos CP 2007) A clinical guide to epileptic syndromes and their treatment. 2nd ed. Springer, London.
34. Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP 1997) Vigabatrin aggravates absences and absence status. Neurology 49 : 1467.
35. Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grunewald RA, Kasteleijn-Nolst-Trenite DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JWAS, Shorvon S, Watanabe K, Whitehouse W, Youroukos S 2004) Efficacy and tolerability of the new antiepileptic drugs; commentary on the recently published practice parameters. Epilepsia 45 : 1646 1649.
36. Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP 1998) Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Dev Med Child Neurol 40 : 517 519.
37. Ross SD, Estok R, Chopra S, French J 2001) Management of newly diagnosed patients with epilepsy: a systematic review of the literature. Evid Rep Technol Assess (Summ.) 1 3.
38. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS 1996) Evidence based medicine: what it is and what it isn't. Br Med J 312 : 71 72.
39. Schapel G, Chadwick D 1996) Tiagabine and non-convulsive status epilepticus. Seizure 5 : 153 156.
40. Shorvon S. (2005) Handbook of epilepsy treatment. 2nd ed. Blackwell Science, Oxford.
41. Shorvon S 2006) We live in the age of the clinical guideline. Epilepsia 47 : 1091 1093.
42. Thomas P, Valton L, Genton P 2006) Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 129 : 1281 1292.
43. Topol EJ 2004) Failing the public health-rofecoxib, Merck, and the FDA. N Engl J Med 351 : 1707 1709.
44. Verity CM, Hosking G, Easter DJ 1995) A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 37 : 97 108.